학술논문
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
Document Type
journal article
Author
Source
Neurology; 6/8/2010, Vol. 74 Issue 23, p1860-1867, 8p
Subject
Language
ISSN
00283878